These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24732000)

  • 1. Active sacral neuromodulator during pregnancy: a unique case report.
    Mamopoulos A; Stavrakis T; Mavromatidis G; Rousso D
    Am J Obstet Gynecol; 2014 Jul; 211(1):e4-5. PubMed ID: 24732000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study].
    Ferhi K; Miaadi N; Tanneau Y; Leroi AM; Sibert L; Grise P
    Prog Urol; 2008 Mar; 18(3):160-6. PubMed ID: 18472068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration of a sacral neuromodulation electrode after vaginal delivery in a female patient with non-obstructive urinary retention.
    El-Akri M; Peyronnet B
    Fr J Urol; 2024 Jun; 34(6):102605. PubMed ID: 38431080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral neuromodulation and pregnancy.
    Wiseman OJ; v d Hombergh U; Koldewijn EL; Spinelli M; Siegel SW; Fowler CJ
    J Urol; 2002 Jan; 167(1):165-8. PubMed ID: 11743297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle fibrillation as a sign of electrode damage in sacral neuromodulation.
    Pannek J; Hinkel A
    Scand J Urol Nephrol; 2006; 40(2):168-9. PubMed ID: 16608818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sacral neuromodulation and sexuality].
    Gamé X
    Prog Urol; 2008 Mar; 18(3):167. PubMed ID: 18472069
    [No Abstract]   [Full Text] [Related]  

  • 9. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pulse rate changes on the clinical outcome of sacral neuromodulation.
    Marcelissen TA; Leong RK; Nieman FH; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2011 May; 185(5):1781-5. PubMed ID: 21420118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic study of women in urinary retention treated with sacral neuromodulation.
    DasGupta R; Fowler CJ
    J Urol; 2004 Mar; 171(3):1161-4. PubMed ID: 14767292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of sacral neuromodulation for women with urinary retention.
    Dasgupta R; Wiseman OJ; Kitchen N; Fowler CJ
    BJU Int; 2004 Aug; 94(3):335-7. PubMed ID: 15291863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromodulation 10 years on: how widely should we use this technique in bladder dysfunction?
    Bolton JF; Harrison SC
    Curr Opin Urol; 2009 Jul; 19(4):375-9. PubMed ID: 19448546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral nerve stimulation during pregnancy: case report and review of the literature.
    El-Khawand D; Montgomery OC; Wehbe SA; Whitmore KE
    Female Pelvic Med Reconstr Surg; 2012; 18(2):127-9. PubMed ID: 22453325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-term experience of sacral neuromodulation by tined lead implantation.
    Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
    BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral Neuromodulation in Pregnant Women-A Case Report and Literature Review.
    Szymański JK; Słabuszewska-Jóźwiak A; Jakiel G
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.
    Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG
    BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction.
    Noblett KL; Cadish LA
    Am J Obstet Gynecol; 2014 Feb; 210(2):99-106. PubMed ID: 23899452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.